1) Northoff G: Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology. J Neural Transm 109: 1453-1467, 2002
2) Taylor MA, Fink M: Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 160: 1233-1241, 2003
3) Levenson JL: Neuroleptic malignant syndrome. Am J Psychiatry 142: 1137-1145, 1985
4) Caroff SN, Mann SC: Neuroleptic malignant syndrome. Med Clin North Am 77: 185-202, 1993
5) 古野 拓, 岸田郁子, 加藤大慈, 河西千秋: 精神科における徴候・症候群の治療指針 悪性症候群. 臨床精神医学35(増): 288-293, 2006
6) 菊池 章,寺尾 敦: 悪性症候群の血液生化学的検査所見と重症化指標. 精神医学48: 37-43, 2006
7) White DA: Catatonia and the neuroleptic malignant syndrome-a single entity? Br J Psychiatry 161: 558-560, 1992
8) Fink M: Neuroleptic malignant syndrome and catatonia: one entity or two? Biol Psychiatry 39: 1-4, 1996
9) Velamoor VR, Norman RM, Caroff SN, Mann SC, Sullivan KA, et al: Progression of symptoms in neuroleptic malignant syndrome. J Nerve Ment Dis 182: 168-173, 1994
10) Singerman B, Raheja R: Malignant catatonia-a continuing reality. Ann Clin Psychiatry 6: 259-266, 1994
11) Miyaoka H, Shishikura K, Otsubo T, Muramatsu D, Kamijima K: Diazepam-responsive neuroleptic malignant syndrome: a diagnostic subtype? Am J Psychiatry 154: 882, 1997
12) 柳川洋一, 宮崎誠樹: ニューロレプト麻酔後, 悪性症候群か緊張病症候群かの鑑別が困難であった症状を呈した1症例. 麻酔59: 235-237, 2010
13) Galynker II, Weiss J, Ongseng F, Finestone H: ECT treatment and cerebral perfusion in Catatonia. J Nucl Med 38: 251-254, 1997
14) Iseki K, Ikeda A, Kihara T, Kawamato Y, Mezaki T, et al: Impairment of the cortical GABAergic inhibitory system in catatonic stupor: a case report with neuroimaging. Epileptic Disord 11: 126-131, 2009